VEGFA and malignant colon neoplasm: TAMs in colon cancer can secrete IL-1, IL-6, and TNF-α, and activate the nuclear factor NF-κB signaling pathway in the vascular endothelium to produce VEGF, which in turn promotes angiogenesis and alters the TME [80].